Catalyst Wire Dossier Catalyst Wire Dossier

Nalbuphine HCl ER Tablets

nalbuphine hydrochloride extended-release · Trevi Therapeutics
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Nalbuphine HCl ER Tablets, covering 2020-08-21 to 2025-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus [Phase 1]

See pricing